Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment
Links shared publicly online about this topic.
- 2,213total visits
Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment
New research out of Wake Forest University School of Medicine identifies the presence of cardiovascular risk factors as an indicator of how likely it is that elderly, hospitalized patients who receive intravenous immunoglobulin treatment will have a stroke or heart attack.
View full resource at eurekalert.org
Tags: Heart, Heart Attack, Stroke, Thrombotic Event, Senior Health
Most Recently Shared on March 5, 2009 at 5:16 am By:
AAAS Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment http://tinyurl.com/b625km
Advertisement
